Home > Geographic Atrophy > Apellis announces 24-month Phase 3 data in geographic atrophy
Apellis announces 24-month Phase 3 data in geographic atrophy
Eleonora Lad, MD, PhD discusses the newly released 24-month Phase 3 results.
This content is independent editorial sponsored by Astellas. Astellas had no input in the development of this content.